Company:

Petrovax

Summary

Petrovax is a Russian biopharmaceutical company established in 1996, specialising in the research, development, and production of innovative vaccines, pharmaceuticals, and biologics. Services provided by NST included:

Messaging and gap analysis based on published/presented data or other communications.
Define clear, measurable communication objectives aligned with organisational or project goals
Identify and segment target audiences.
Target the most effective communication platforms (e.g., social media, email, traditional media)
Develop a detailed plan with specific activities, timelines, and responsibilities
Use the NST medical writing team to create and coordinate dissemination of the message vehicles as per the timeline.

What our client said

"As a medium cap business we make a balance between large scale projects and nimble execution. We value the quality, focus and dedication that external providers bring to our projects. That is exactly what we found with NST. The quality of the work delivered by the Niche teams and their attitude to our projects have always been of the highest standard. NST are proactive, eager to share their insights, provide guidance where necessary and generally augment our projects."

Mikhail Tsyferov

Petrovax

Request copy of the testimonial

Project background

Petrovax is a Russian biopharmaceutical company established in 1996, specialising in the research, development, and production of innovative vaccines, pharmaceuticals, and biologics. The company operates as a full-cycle manufacturer, handling everything from the synthesis of active pharmaceutical ingredients (APIs) to the production of sterile and non-sterile medicines. Petrovax is particularly focused on immunological and viral disease therapies, with notable products such as the influenza vaccine Grippol® and the immunomodulator Polyoxidonium®. The company has a strong record in international collaboration and localisation, partnering with global firms like Pfizer and CanSino Biologics. During the COVID-19 pandemic, it played a key role in vaccine development and distribution. Petrovax continues to expand its presence with patented technologies and therapeutic innovations.

Delivery

Petrovax approached NST at the start of the COVID-19 pandemic looking for support in the conduct of the clinical operations and dissemination activities around their portfolio of innovative vaccines, pharmaceuticals, and biologics, and the potential benefits they might have in addressing the spread of the disease. The NST medical writing team first performed a gap analysis around the reporting of the clinical evidence collected by Petrovax in the scientific literature. After this, NST created a strategic communication plan for the Longidaza, Polyoxidonium and Grippol products that addressed the company's strategic goals, the underlying scientific messages and available channels for dissemination.

The NST team was engaged to deliver the various communication vehicles key to the plan's implementation, involving the provision of editorial and medical writing support, including regulatory documents, scientific manuscripts, conference publications, etc.

Related Case studies

Cardionetics is an innovative hardware and software solutions company specialising in providing intelligent systems for diagnostic, monitoring, and screening purposes.

Cardionetics is an innovative hardware and software solutions company specialising in providing intelligent systems for.

+ 44 (0)20 8332 2588

Company:

Petrovax

Petrovax

Petrovax

Related Case studies

ApaTech

A medical device company that was involved in the manufacturing of orthobiologics.

Cardionetics

Cardionetics is an innovative hardware and software solutions company specialising in providing intelligent systems for diagnostic, monitoring, and screening purposes.